Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Consideration of Muscle Depth for Botulinum Toxin Injections: A Three-Dimensional Approach.

Kaplan JB.

Plast Surg Nurs. 2019 Apr/Jun;39(2):52-58. doi: 10.1097/PSN.0000000000000265.

PMID:
31136559
2.

Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era.

Gerson JN, Handorf E, Villa D, Gerrie AS, Chapani P, Li S, Medeiros LJ, Wang MI, Cohen JB, Calzada O, Churnetski MC, Hill BT, Sawalha Y, Hernandez-Ilizaliturri FJ, Kothari S, Vose JM, Bast MA, Fenske TS, Narayana Rao Gari S, Maddocks KJ, Bond D, Bachanova V, Kolla B, Chavez J, Shah B, Lansigan F, Burns TF, Donovan AM, Wagner-Johnston N, Messmer M, Mehta A, Anderson JK, Reddy N, Kovach AE, Landsburg DJ, Glenn M, Inwards DJ, Karmali R, Kaplan JB, Caimi PF, Rajguru S, Evens A, Klein A, Umyarova E, Pulluri B, Amengual JE, Lue JK, Diefenbach C, Fisher RI, Barta SK.

J Clin Oncol. 2019 Feb 20;37(6):471-480. doi: 10.1200/JCO.18.00690. Epub 2019 Jan 7.

PMID:
30615550
3.

μImpact of a nursing-driven sedation protocol with criteria for infusion initiation in the surgical intensive care unit.

Kaplan JB, Eiferman DS, Porter K, MacDermott J, Brumbaugh J, Murphy CV.

J Crit Care. 2019 Apr;50:195-200. doi: 10.1016/j.jcrc.2018.11.029. Epub 2018 Nov 30.

PMID:
30553990
4.

Transcriptomic heterogeneity in multifocal prostate cancer.

Salami SS, Hovelson DH, Kaplan JB, Mathieu R, Udager AM, Curci NE, Lee M, Plouffe KR, de la Vega LL, Susani M, Rioux-Leclercq N, Spratt DE, Morgan TM, Davenport MS, Chinnaiyan AM, Cyrta J, Rubin MA, Shariat SF, Tomlins SA, Palapattu GS.

JCI Insight. 2018 Nov 2;3(21). pii: 123468. doi: 10.1172/jci.insight.123468.

5.

Extracellular polymeric substance (EPS)-degrading enzymes reduce staphylococcal surface attachment and biocide resistance on pig skin in vivo.

Kaplan JB, Mlynek KD, Hettiarachchi H, Alamneh YA, Biggemann L, Zurawski DV, Black CC, Bane CE, Kim RK, Granick MS.

PLoS One. 2018 Oct 10;13(10):e0205526. doi: 10.1371/journal.pone.0205526. eCollection 2018.

6.

Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.

de Wispelaere M, Lian W, Potisopon S, Li PC, Jang J, Ficarro SB, Clark MJ, Zhu X, Kaplan JB, Pitts JD, Wales TE, Wang J, Engen JR, Marto JA, Gray NS, Yang PL.

Cell Chem Biol. 2018 Aug 16;25(8):1006-1016.e8. doi: 10.1016/j.chembiol.2018.05.011. Epub 2018 Jun 21.

PMID:
29937406
7.

Hemophagocytic Lymphohistiocytosis in Cutaneous T-Cell Lymphoma.

Lee DE, Martinez-Escala ME, Serrano LM, Zhou XA, Kaplan JB, Pro B, Choi J, Guitart J.

JAMA Dermatol. 2018 Jul 1;154(7):828-831. doi: 10.1001/jamadermatol.2018.1264.

8.

An Extremely Rapid Case of Pneumonitis with the Use of Nivolumab for Pancreatic Adenocarcinoma.

Costa RB, Benson A, Yaghmai V, Costa RLB, Zhou H, Behdad A, Kaplan JB, Sadim M, Talamantes S, Kalyan A.

Case Rep Oncol Med. 2018 Apr 1;2018:6314392. doi: 10.1155/2018/6314392. eCollection 2018.

9.

Systematic review and meta-analysis of selected toxicities of approved ALK inhibitors in metastatic non-small cell lung cancer.

Costa RB, Costa RLB, Talamantes SM, Kaplan JB, Bhave MA, Rademaker A, Miller C, Carneiro BA, Mahalingam D, Chae YK.

Oncotarget. 2018 Apr 24;9(31):22137-22146. doi: 10.18632/oncotarget.25154. eCollection 2018 Apr 24.

10.

Prospective Observational Evaluation of Sedation and Pain Management Guideline Adherence Across New Jersey Intensive Care Units.

Brophy A, Cardinale M, Andrews LB, Kaplan JB, Adams C, Opsha Y, Brandt KA, Dixit D, Nerenberg SF, Saleh JA.

J Pharm Pract. 2018 Jan 1:897190018770549. doi: 10.1177/0897190018770549. [Epub ahead of print]

PMID:
29685062
11.

Technical feasibility, diagnostic yield, and safety of microforceps biopsies during EUS evaluation of pancreatic cystic lesions (with video).

Mittal C, Obuch JC, Hammad H, Edmundowicz SA, Wani S, Shah RJ, Brauer BC, Attwell AR, Kaplan JB, Wagh MS.

Gastrointest Endosc. 2018 May;87(5):1263-1269. doi: 10.1016/j.gie.2017.12.025. Epub 2018 Jan 6.

PMID:
29309781
12.

Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor-alpha therapy.

Martinez-Escala ME, Posligua AL, Wickless H, Rutherford A, Sable KA, Rubio-Gonzalez B, Zhou XA, Kaplan JB, Pro B, Choi J, Querfeld C, Rosen ST, Guitart J.

J Am Acad Dermatol. 2018 Jun;78(6):1068-1076. doi: 10.1016/j.jaad.2017.12.068. Epub 2018 Jan 4.

13.

Detection of Alkynes via Click Chemistry with a Brominated Coumarin Azide by Simultaneous Fluorescence and Isotopic Signatures in Mass Spectrometry.

Yang L, Chumsae C, Kaplan JB, Moulton KR, Wang D, Lee DH, Zhou ZS.

Bioconjug Chem. 2017 Sep 20;28(9):2302-2309. doi: 10.1021/acs.bioconjchem.7b00354. Epub 2017 Sep 11.

PMID:
28825803
14.

CD8+ mycosis fungoides: A low-grade lymphoproliferative disorder.

Martinez-Escala ME, Kantor RW, Cices A, Zhou XA, Kaplan JB, Pro B, Choi J, Guitart J.

J Am Acad Dermatol. 2017 Sep;77(3):489-496. doi: 10.1016/j.jaad.2017.05.015. Epub 2017 Jul 1.

PMID:
28676328
15.

Wnt/beta-catenin pathway: modulating anticancer immune response.

Pai SG, Carneiro BA, Mota JM, Costa R, Leite CA, Barroso-Sousa R, Kaplan JB, Chae YK, Giles FJ.

J Hematol Oncol. 2017 May 5;10(1):101. doi: 10.1186/s13045-017-0471-6. Review.

16.

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.

Landsburg DJ, Falkiewicz MK, Maly J, Blum KA, Howlett C, Feldman T, Mato AR, Hill BT, Li S, Medeiros LJ, Torka P, Hernandez-Ilizaliturri F, Reddy NM, Singavi A, Fenske TS, Chavez JC, Kaplan JB, Behdad A, Petrich AM, Bast MA, Vose JM, Olszewski AJ, Costa C, Lansigan F, Gerson JN, Barta SK, Calzada O, Cohen JB, Lue JK, Amengual JE, Rivera X, Persky DO, Peace DJ, Nathan S, Cassaday RD.

J Clin Oncol. 2017 Jul 10;35(20):2260-2267. doi: 10.1200/JCO.2017.72.2157. Epub 2017 May 5.

17.

Consideration of Muscle Depth for Botulinum Toxin Injections: A Three-Dimensional Approach.

Kaplan JB.

Plast Surg Nurs. 2017 Jan/Mar;37(1):32-38. doi: 10.1097/PSN.0000000000000172.

PMID:
28244963
18.

Another tyrosine kinase inhibitor-resistance mutation within the BCR-ABL kinase domain: chasing our tails?

Kaplan JB, Platanias LC.

Leuk Lymphoma. 2017 Jul;58(7):1526-1527. doi: 10.1080/10428194.2017.1283034. Epub 2017 Jan 31. No abstract available.

PMID:
28140710
19.

In vitro characterization of biofilms formed by Kingella kingae.

Kaplan JB, Sampathkumar V, Bendaoud M, Giannakakis AK, Lally ET, Balashova NV.

Mol Oral Microbiol. 2017 Aug;32(4):341-353. doi: 10.1111/omi.12176. Epub 2016 Dec 12.

20.

The Value of Full Correction: Achieving Excellent and Affordable Results.

Kaplan JB.

Plast Surg Nurs. 2016 Jul-Sep;36(3):110-3. doi: 10.1097/PSN.0000000000000151.

PMID:
27606585
21.

Response to the Letter to the Editor.

Kaplan JB.

Plast Surg Nurs. 2016 Jul-Sep;36(3):99. doi: 10.1097/PSN.0000000000000147. No abstract available.

PMID:
27606581
22.

Long-acting interferon for myeloproliferative neoplasms - an update.

Pai SG, Kaplan JB, Giles FJ.

Expert Rev Hematol. 2016 Oct;9(10):915-7. doi: 10.1080/17474086.2016.1231571. Epub 2016 Sep 13. No abstract available.

PMID:
27584865
23.

Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.

Sogani J, Morris EA, Kaplan JB, D'Alessio D, Goldman D, Moskowitz CS, Jochelson MS.

Radiology. 2017 Jan;282(1):63-73. doi: 10.1148/radiol.2016160284. Epub 2016 Jul 4.

24.

Sub-inhibitory tigecycline concentrations induce extracellular matrix binding protein Embp dependent Staphylococcus epidermidis biofilm formation and immune evasion.

Weiser J, Henke HA, Hector N, Both A, Christner M, Büttner H, Kaplan JB, Rohde H.

Int J Med Microbiol. 2016 Sep;306(6):471-8. doi: 10.1016/j.ijmm.2016.05.015. Epub 2016 May 25.

PMID:
27292911
25.

Multidisciplinary management for esophageal and gastric cancer.

Boniface MM, Wani SB, Schefter TE, Koo PJ, Meguid C, Leong S, Kaplan JB, Wingrove LJ, McCarter MD.

Cancer Manag Res. 2016 Apr 22;8:39-44. doi: 10.2147/CMAR.S101169. eCollection 2016. Review.

26.

The challenge of developmental therapeutics for adrenocortical carcinoma.

Costa R, Carneiro BA, Tavora F, Pai SG, Kaplan JB, Chae YK, Chandra S, Kopp PA, Giles FJ.

Oncotarget. 2016 Jul 19;7(29):46734-46749. doi: 10.18632/oncotarget.8774. Review.

27.

Durable Responses With Maintenance Dose-Sparing Regimens of Romidepsin in Cutaneous T-Cell Lymphoma.

Martinez-Escala ME, Kuzel TM, Kaplan JB, Petrich A, Nardone B, Rosen ST, Guitart J.

JAMA Oncol. 2016 Jun 1;2(6):790-3. doi: 10.1001/jamaoncol.2016.0004.

PMID:
27054291
28.

Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives.

Costa R, Carneiro BA, Chandra S, Pai SG, Chae YK, Kaplan JB, Garrett HB, Agulnik M, Kopp PA, Giles FJ.

Drug Des Devel Ther. 2016 Feb 29;10:873-84. doi: 10.2147/DDDT.S93459. eCollection 2016. Review.

29.

Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms.

Kaplan JB, Stein BL, McMahon B, Giles FJ, Platanias LC.

EBioMedicine. 2016 Jan 13;3:17-25. doi: 10.1016/j.ebiom.2016.01.010. eCollection 2016 Jan. Review.

30.

Effects of Low-Dose Amoxicillin on Staphylococcus aureus USA300 Biofilms.

Mlynek KD, Callahan MT, Shimkevitch AV, Farmer JT, Endres JL, Marchand M, Bayles KW, Horswill AR, Kaplan JB.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):2639-51. doi: 10.1128/AAC.02070-15. Print 2016 May.

31.

SNPing away to individualize induction therapy for acute myelogenous leukemia.

Kaplan JB, Altman JK, Platanias LC.

Leuk Lymphoma. 2016;57(4):742-3. doi: 10.3109/10428194.2015.1136743. Epub 2016 Jan 19. No abstract available.

PMID:
26784362
32.

Blinatumomab for the treatment of acute lymphoblastic leukemia.

Kaplan JB, Grischenko M, Giles FJ.

Invest New Drugs. 2015 Dec;33(6):1271-9. doi: 10.1007/s10637-015-0289-4. Epub 2015 Sep 17. Review.

PMID:
26383529
33.

Tyrosine kinase inhibitor therapy in chronic myeloid leukemia: update on key adverse events.

Carneiro BA, Kaplan JB, Giles FJ.

Expert Rev Hematol. 2015 Aug;8(4):457-79. doi: 10.1586/17474086.2015.1041910. Epub 2015 May 4. Review.

PMID:
25938861
34.

Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia.

Carneiro BA, Kaplan JB, Altman JK, Giles FJ, Platanias LC.

Cancer Biol Ther. 2015;16(5):648-56. doi: 10.1080/15384047.2015.1026510. Review.

35.

Aesthetic self-esteem.

Kaplan JB.

Plast Surg Nurs. 2015 Jan-Mar;35(1):33-9. doi: 10.1097/PSN.0000000000000085. Review.

PMID:
25730537
36.

Role of exopolysaccharide in Aggregatibacter actinomycetemcomitans-induced bone resorption in a rat model for periodontal disease.

Shanmugam M, Gopal P, El Abbar F, Schreiner HC, Kaplan JB, Fine DH, Ramasubbu N.

PLoS One. 2015 Feb 23;10(2):e0117487. doi: 10.1371/journal.pone.0117487. eCollection 2015.

37.

Data-driven prediction and design of bZIP coiled-coil interactions.

Potapov V, Kaplan JB, Keating AE.

PLoS Comput Biol. 2015 Feb 19;11(2):e1004046. doi: 10.1371/journal.pcbi.1004046. eCollection 2015 Feb. Erratum in: PLoS Comput Biol. 2015 Apr;11(4):e1004243.

38.

Radial Scar at Image-guided Needle Biopsy: Is Excision Necessary?

Conlon N, D'Arcy C, Kaplan JB, Bowser ZL, Cordero A, Brogi E, Corben AD.

Am J Surg Pathol. 2015 Jun;39(6):779-85. doi: 10.1097/PAS.0000000000000393.

39.

Targeted therapy of acute myeloid leukemia.

Carneiro BA, Altman JK, Kaplan JB, Ossenkoppele G, Swords R, Platanias LC, Giles FJ.

Expert Rev Anticancer Ther. 2015 Apr;15(4):399-413. doi: 10.1586/14737140.2015.1004316. Epub 2015 Jan 26. Review.

PMID:
25623136
40.

Predicting resistance to dasatinib therapy for patients with Philadelphia-positive leukemia with prior tyrosine kinase inhibitor failure.

Kaplan JB, Platanias LC, Giles FJ.

Leuk Lymphoma. 2015 Jul;56(7):1922-3. doi: 10.3109/10428194.2014.999332. Epub 2015 Jan 21. No abstract available.

PMID:
25535817
41.

Characterisation of pellicles formed by Acinetobacter baumannii at the air-liquid interface.

Nait Chabane Y, Marti S, Rihouey C, Alexandre S, Hardouin J, Lesouhaitier O, Vila J, Kaplan JB, Jouenne T, Dé E.

PLoS One. 2014 Oct 31;9(10):e111660. doi: 10.1371/journal.pone.0111660. eCollection 2014.

42.

Environmental bacteria produce abundant and diverse antibiofilm compounds.

Farmer JT, Shimkevitch AV, Reilly PS, Mlynek KD, Jensen KS, Callahan MT, Bushaw-Newton KL, Kaplan JB.

J Appl Microbiol. 2014 Dec;117(6):1663-73. doi: 10.1111/jam.12639. Epub 2014 Sep 26.

43.

Targeted therapies for cutaneous T-cell lymphomas.

Kaplan JB, Guitart J, Giles FJ.

Expert Rev Hematol. 2014 Aug;7(4):481-93. doi: 10.1586/17474086.2014.942279. Review.

PMID:
25025372
44.

Increasing the affinity of selective bZIP-binding peptides through surface residue redesign.

Kaplan JB, Reinke AW, Keating AE.

Protein Sci. 2014 Jul;23(7):940-53. doi: 10.1002/pro.2477. Epub 2014 Apr 30.

45.

Biofilm matrix-degrading enzymes.

Kaplan JB.

Methods Mol Biol. 2014;1147:203-13. doi: 10.1007/978-1-4939-0467-9_14.

PMID:
24664835
46.

Induction of MRSA Biofilm by Low-Dose β-Lactam Antibiotics: Specificity, Prevalence and Dose-Response Effects.

Ng M, Epstein SB, Callahan MT, Piotrowski BO, Simon GL, Roberts AD, Keiser JF, Kaplan JB.

Dose Response. 2013 Jul 25;12(1):152-61. doi: 10.2203/dose-response.13-021.Kaplan. eCollection 2014 Jan.

47.

Intravoxel incoherent motion diffusion-weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchyma.

Bokacheva L, Kaplan JB, Giri DD, Patil S, Gnanasigamani M, Nyman CG, Deasy JO, Morris EA, Thakur SB.

J Magn Reson Imaging. 2014 Oct;40(4):813-23. doi: 10.1002/jmri.24462. Epub 2013 Nov 22.

48.

Characterization of TEM-1 β-Lactamase-Producing Kingella kingae Clinical Isolates.

Banerjee A, Kaplan JB, Soherwardy A, Nudell Y, Mackenzie GA, Johnson S, Balashova NV.

Antimicrob Agents Chemother. 2013 Sep;57(9):4300-4306. doi: 10.1128/AAC.00318-13. Epub 2013 Jun 24.

49.

Antibiofilm activity of Actinobacillus pleuropneumoniae serotype 5 capsular polysaccharide.

Karwacki MT, Kadouri DE, Bendaoud M, Izano EA, Sampathkumar V, Inzana TJ, Kaplan JB.

PLoS One. 2013 May 14;8(5):e63844. doi: 10.1371/journal.pone.0063844. Print 2013.

50.

Noneluting enzymatic antibiofilm coatings.

Pavlukhina SV, Kaplan JB, Xu L, Chang W, Yu X, Madhyastha S, Yakandawala N, Mentbayeva A, Khan B, Sukhishvili SA.

ACS Appl Mater Interfaces. 2012 Sep 26;4(9):4708-16. Epub 2012 Sep 4.

Supplemental Content

Loading ...
Support Center